Drug Information Association Logo
Corporate Tagline

Trends in Health Canada Inspections

Oct 28 2013 1:30PM - Oct 28 2013 5:00PM | Ottawa Marriott Hotel 100 Kent Street Ottawa, ON K1P5R7 CANADA

« Back to Listing


This tutorial will focus on recent trends in Health Canada Inspections from the perspective of the Inspectorate and the Industry it regulates.

Following an overview of the Inspectorate and the Inspection strategy for drugs, biologics and medical devices, the Inspectorate and Industry will discuss emerging trends.

For GMP and medical devices inspections, the Inspectorate will present a summary of top observations, including examples on GMP, medical devices and clinical trial inspections.  Industry speakers will discuss how recent inspection observations have changed their operational practices in Canada and globally.

Additionally, HPFBI will provide Industry with advice on areas considered “grey space.”

Follow this link for more information.


Learning Objectives 

At the conclusion of this tutorial, participants should be able to:

  • Discuss the HPFBI’s current mandate and operations for GMP oversight in the areas of drugs and medical device manufacturing, importing and distribution.
  • Describe how Industry should prepare for drug, biologics and medical device inspections by gaining knowledge of recent inspection findings and issues and how some companies have adapted operations to respond.
  • Apply advice from the Inspectorate on managing topics that drug and medical device manufacturers, importers and distributors seek clarity on.



Previous Next

Unless otherwise disclosed, the statements made by speakers represent their own opinions and not necessarily those of the organization they represent, or that of the Drug Information Association. Speakers, agenda and CE information are subject to change without notice. Recording of any DIA educational material in any type of media is prohibited without prior written consent from DIA.

« Back to Listing Back To Top